Literature DB >> 14760270

First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.

Yann Mikaeloff1, Samy Suissa, Louis Vallée, Catherine Lubetzki, Gérard Ponsot, Christian Confavreux, Marc Tardieu.   

Abstract

OBJECTIVES: To evaluate prognostic factors for second attack and for disability in children presenting with an initial episode of central nervous system (CNS) demyelination. STUDY
DESIGN: A cohort of 296 children having a first episode of acute CNS inflammatory demyelination was studied by survival analysis.
RESULTS: The average follow-up was 2.9+/-3 years. At the end of the follow-up, 57% of patients had a diagnosis of multiple sclerosis (MS), 29% had a monophasic acute disseminated encephalomyelitis, and 14% had a single focal episode. The rate of a second attack was (1). higher in patients with age at onset >or=10 years (hazard ratio, 1.67; 95% CI, 1.04-2.67), MS-suggestive initial MRI (1.54; 1.02-2.33), or optic nerve lesion (2.59; 1.27-5.29); and (2). lower in patients with myelitis (0.23; 0.10-0.56) or mental status change (0.59; 0.33-1.07). Of patients with a second attack, 29% had an initial diagnosis of acute disseminated encephalomyelitis. At the end of the follow-up period, 90% of patients had no or minor disability. Occurrence of severe disability was associated with a polysymptomatic onset (3.25; 1.16-11.01), sequelae after the first attack (26.65; 9.42-75.35), further relapses (1.49; 1.16-1.92), and progressive MS (3.57; 1.21-8.72).
CONCLUSIONS: Risk of second attack of CNS demyelination is higher in older patients and lower in patients with mental status change. Risk of disability is higher in polysymptomatic and relapsing patients.

Entities:  

Mesh:

Year:  2004        PMID: 14760270     DOI: 10.1016/j.jpeds.2003.10.056

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  56 in total

1.  The course of early-onset multiple sclerosis in Iraqi children.

Authors:  Hasan A Al-Hamadani; Atheer S Abdalla; Atheer J Al-Saffar
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Childhood multiple sclerosis and related disorders.

Authors:  Amna Al-Futaisi
Journal:  Oman Med J       Date:  2007-10

Review 3.  Imaging in Pediatric Demyelinating and Inflammatory Diseases of the Brain- Part 1.

Authors:  Sniya Valsa Sudhakar; Karthik Muthusamy; Sunithi Mani; Sridhar Gibikote; Manohar Shroff
Journal:  Indian J Pediatr       Date:  2015-12-04       Impact factor: 1.967

Review 4.  Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis?

Authors:  R C Dale; J A Branson
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

5.  HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.

Authors:  G Disanto; S Magalhaes; A E Handel; K M Morrison; A D Sadovnick; G C Ebers; B Banwell; A Bar-Or
Journal:  Neurology       Date:  2011-02-02       Impact factor: 9.910

Review 6.  [Acute disseminated encephalomyelitis].

Authors:  M Politi; P Papanagiotou; I Q Grunwald; C Roth; W Reith
Journal:  Radiologe       Date:  2008-06       Impact factor: 0.635

7.  Acute disseminated encephalomyelitisin the intensive care unit:clinical features and outcome of 20 adults.

Authors:  Romain Sonneville; Sophie Demeret; Isabelle Klein; Lila Bouadma; Bruno Mourvillier; Juliette Audibert; Stéphane Legriel; Francis Bolgert; Bernard Regnier; Michel Wolff
Journal:  Intensive Care Med       Date:  2007-11-09       Impact factor: 17.440

Review 8.  Demyelinating diseases.

Authors:  S Love
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

Review 9.  Disease-modifying therapy of pediatric multiple sclerosis.

Authors:  Tanuja Chitnis
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

Review 10.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.